Director David Pacitti filed a Form 4 with the SEC on November 9, 2026, disclosing the purchase of 20,000 shares of Orchestra BioMed Holdings, Inc. common stock at $5.00 per share in an underwritten public offering.

Key Highlights

  • Transaction: David Pacitti acquired 20,000 shares of common stock (par value $0.0001 per share) on November 9, 2026.
  • Price: Shares were purchased at the public offering price of $5.00 per share.
  • Context: According to the filing, the shares were purchased in an underwritten public offering of the issuer.
  • Resulting ownership: Following the transaction, Pacitti directly holds 74,750 shares of common stock, per the filing.
  • Role: Pacitti is identified as a Director of Orchestra BioMed Holdings, Inc.

Director Pacitti's Open-Market Purchase in Orchestra BioMed Public Offering

According to the Form 4 filed with the SEC on November 9, 2026, David Pacitti, a director of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), acquired 20,000 shares of the company's common stock. The filing records the transaction code as "P," indicating a purchase. The shares carry a par value of $0.0001 per share and were acquired directly by Pacitti.

The filing's footnote states that "these shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share." The transaction date is listed as November 9, 2026, with no deemed execution date noted. Following this acquisition, Pacitti's direct beneficial ownership of Orchestra BioMed common stock stands at 74,750 shares, as reported in the filing.

No derivative securities transactions were reported in Table II of this filing. The form was signed by Andrew Taylor as attorney-in-fact on behalf of Pacitti, also dated November 9, 2026. The filing indicates it was made by one reporting person and is not an amendment to a prior form.

What Was Disclosed

Director David Pacitti disclosed a purchase of 20,000 shares of Orchestra BioMed Holdings common stock at $5.00 per share in an underwritten public offering on November 9, 2026, bringing his direct beneficial ownership to 74,750 shares.